Morasa Sheikhy

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Morasa Sheikhy, Sarah J Schrieber, Qin Sun, Victoria Gershuny, Murali K Matta, Jane P F Bai, Xiulian Du, Giri Vegesna, Aanchal Shah, Kristin Prentice, Colleen Nalepinski, Issam Zineh, Yow-Ming C Wang, David G Strauss, Jeffry Florian
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (I) A Randomized Trial with PCSK9 Inhibitors. Clinical pharmacology and therapeutics (2022)
Jeffry Florian, Victoria Gershuny, Qin Sun, Sarah J Schrieber, Murali K Matta, Anthony Hazel, Morasa Sheikhy, James L Weaver, Paula L Hyland, Cheng-Hui Hsiao, Giri Vegesna, Ryan DePalma, Aanchal Shah, Kristin Prentice, Carlos Sanabria, Yow-Ming C Wang, David G Strauss
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (III) A Randomized Trial with Interferon Beta-1a Products. Clinical pharmacology and therapeutics (2022)
Jeffry Florian, Qin Sun, Sarah J Schrieber, Richard White, Sophie Shubow, Bernadette E Johnson-Williams, Morasa Sheikhy, Nicholas R Harrison, Valerie J Parker, Yow-Ming C Wang, David G Strauss
Pharmacodynamic Biomarkers for Biosimilar Development and Approval: A Workshop Summary. Clinical pharmacology and therapeutics (2022)
Victoria Gershuny, Qin Sun, Sarah J Schrieber, Murali K Matta, James L Weaver, Ping Ji, Morasa Sheikhy, Cheng-Hui Hsiao, Giri Vegesna, Aanchal Shah, Kristin Prentice, Jennifer Deering, Yow-Ming C Wang, David G Strauss, Jeffry Florian
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (II) A Randomized Trial with IL-5 Antagonists. Clinical pharmacology and therapeutics (2022)